查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1842321

全球人工智慧醫療設備市場：市場規模、佔有率和趨勢分析（按組件、技術、治療領域、最終用途和地區分類），細分市場預測（2025-2033 年）

AI-enabled Medical Devices Market Size, Share & Trends Analysis Report By Component (Software, Hardware), By Technology (Machine Learning, NLP), By Therapeutic Area, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

人工智慧賦能型醫療設備：市場概覽

全球人工智慧醫療設備市場預計在 2024 年達到 136.7 億美元，預計到 2033 年將達到 2,557.6 億美元，2025 年至 2033 年的複合年成長率為 38.5%。

個人化和精準醫療的日益普及、醫學影像和診斷技術的進步以及有利的監管和報銷環境，都促進了市場成長。

此外，醫療保健領域的數位化不斷提高、投資增加以及產業合作加強也是推動市場成長的其他因素。個人化醫療將透過基於個人基因、環境和生活方式的客製化醫療，推動人工智慧醫療設備的普及應用。人工智慧系統透過分析基因組數據、影像掃描和臨床記錄，為精準治療提供可操作的洞察。這些技術有助於根據個人化醫療通訊協定，實現疾病的早期檢測、風險分層和治療監測。

此外，先進的預測分析技術能夠幫助臨床醫師更好地管理病患健康，主動改善臨床療效。例如，2025年1月，Lunit 的人工智慧組織分析軟體 Lunit SCOPE IO 獲得 FDA 510(k) 許可，該軟體專為腫瘤免疫學設計。此解決方案有助於識別癌組織中的腫瘤浸潤淋巴細胞 (TIL)，從而支持精準免疫療法決策。

此外，人工智慧演算法（例如深度學習、自然語言處理和電腦視覺）的進步正在提升人工智慧醫療設備的效能。演算法精度的提高能夠提升診斷準確率並降低錯誤率。這些技術進步將推動包括基於人工智慧的成像、風險預測建模和自動化病患監測的各種應用的蓬勃發展。例如，2025年6月，Clarity公司憑藉其創新平台CLAIRITY BREAST，成為第一個獲得FDA批准的乳癌預測人工智慧平台。該平台僅需常規乳房X光檢查即可預測女性未來五年罹患乳癌的風險。

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章：人工智慧賦能醫療設備市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 人工智慧賦能的醫療設備市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL 分析

第4章：人工智慧醫療設備市場：按組件分類的估算與趨勢分析

  • 細分儀表板
  • 全球人工智慧醫療設備市場：按組件分類的波動分析
  • 全球人工智慧醫療設備市場規模及趨勢分析（按組件分類）（2021-2033 年）
  • 軟體
  • 硬體
    • 人工智慧醫療設備
    • 智慧型穿戴裝置
  • 服務

第5章：人工智慧醫療設備市場：按技術分類的估算與趨勢分析

  • 細分儀表板
  • 全球人工智慧醫療設備市場：按技術分類的趨勢分析
  • 全球人工智慧醫療設備市場規模及趨勢分析（按技術分類）（2021-2033 年）
  • 機器學習演算法
    • 深度學習
    • 受監督
    • 無人監管
    • 其他
  • 自然語言處理（NLP）
  • 電腦視覺技術
  • 情境感知感知計算

第6章：人工智慧醫療設備市場：按治療領域分類的估算與趨勢分析

  • 細分儀表板
  • 全球人工智慧醫療設備市場：按治療領域分類的趨勢分析
  • 全球人工智慧醫療設備市場規模及趨勢分析（按治療領域分類，2021-2033 年）
  • 心臟病
  • 神經科
  • 放射科
  • 瘤
  • 心理健康和行為健康
  • 眼科
  • 其他

第7章：人工智慧賦能的醫療設備市場：依最終用途分類的估算與趨勢分析

  • 細分儀表板
  • 全球人工智慧醫療設備市場：按最終用途分類的趨勢分析
  • 全球人工智慧醫療設備市場規模及趨勢分析（按最終用途分類）（2021-2033 年）
  • 醫院和診所
  • 診斷中心
  • 門診手術中心（ASC）
  • 居家醫療
  • 其他

第8章：人工智慧醫療設備市場：區域估算與趨勢分析

  • 按地區分類的市場佔有率分析（2024 年和 2033 年）
  • 市場概覽：按地區
  • 市場規模預測及趨勢分析（2021-2033）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 公司/競爭對手分類
  • 策略規劃
  • 企業市場分析（2024）
  • 公司簡介/上市公司
    • Siemens Healthineers
    • GE Healthcare
    • Philips Healthcare
    • Medtronic
    • Johnson & Johnson（Ethicon）
    • Stryker
    • Canon Medical Systems
    • Zimmer Biomet
    • Abbott Laboratories
    • Boston Scientific
    • Exo Imaging, Inc.
    • Empatica
    • Aidoc
    • Clew Medical
    • Eko Health
    • Paige AI, Inc.
Product Code: GVR-4-68040-731-9

AI-Enabled Medical Devices Market Summary

The global AI-enabled medical devices market size was estimated at USD 13.67 billion in 2024 and is projected to reach USD 255.76 billion by 2033, growing at a CAGR of 38.5% from 2025 to 2033. Growing adoption of personalized and precision medicine, medical imaging and diagnostics advancements, and a supportive regulatory and reimbursement landscape contribute to market growth.

In addition, increasing healthcare digitalization and rising investments and industry collaborations are some other factors fueling market growth further. Personalized medicine drives the adoption of AI-enabled medical devices by enabling tailored healthcare based on individual genetics, environment, and lifestyle. By analyzing genomic data, imaging scans, and clinical records, AI systems deliver actionable insights for precision therapies. These technologies facilitate early disease detection, risk stratification, and treatment monitoring aligned with personalized medical protocols.

Furthermore, advanced predictive analytics empower clinicians to manage patient health, proactively improving clinical outcomes. For instance, in January 2025, Lunit received FDA 510(k) clearance for its Lunit SCOPE IO, an AI-powered tissue analysis software designed for immuno-oncology. The solution helps identify tumor-infiltrating lymphocytes (TILs) in cancer tissues, supporting precision immunotherapy decisions.

Moreover, the evolution of AI algorithms, including deep learning, natural language processing, and computer vision, propels AI medical device capabilities. Improved algorithm accuracy enhances diagnostic precision and reduces error rates. These technological improvements facilitate expanded applications, including AI-assisted imaging, predictive risk modeling, and automated patient monitoring. For instance, in June 2025, Clairity, Inc. became the first FDA-authorized AI platform for breast cancer prediction, receiving De Novo authorization for CLAIRITY BREAST. This innovative platform predicts a woman's five-year risk of developing breast cancer using only routine screening mammograms.

Global AI-enabled Medical Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global AI-enabled medical devices market report based on component, technology, therapeutic area, end use, and region:

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Hardware
    • AI-enabled Medical Devices
    • Smart Wearables
  • Services
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Machine Learning
    • Deep learning
    • Supervised
    • Unsupervised
    • Others
  • Natural Language Processing (NLP)
  • Computer Vision
  • Context-Aware Computing
  • Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Cardiology
  • Neurology
  • Radiology
  • Oncology
  • Mental and Behavioral Health
  • Ophthalmology
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Diagnostic Centers
  • Ambulatory Surgical Centers (ASCs)
  • Home Care Settings
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Component Segment
    • 1.2.2. Technology Segment
    • 1.2.3. Therapeutic Area Segment
    • 1.2.4. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. AI-Enabled Medical Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for early disease diagnosis and predictive healthcare
      • 3.2.1.2. Increasing adoption of personalized medicine and precision healthcare approaches.
      • 3.2.1.3. Growing use of wearables and remote patient monitoring devices.
      • 3.2.1.4. Advancements in machine learning, deep learning, and big data analytics enabling smarter devices.
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Data security and privacy concerns
      • 3.2.2.2. High costs of advanced devices
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. AI-Enabled Medical Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape

Chapter 4. AI-Enabled Medical Devices Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global AI-Enabled Medical Devices Market Component Movement Analysis
  • 4.3. Global AI-Enabled Medical Devices Market Size & Trend Analysis, by Component, 2021 - 2033 (USD Million)
  • 4.4. Software
    • 4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Hardware
    • 4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. AI-enabled Medical Devices
      • 4.5.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Smart Wearables
      • 4.5.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Services
    • 4.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. AI-Enabled Medical Devices Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global AI-Enabled Medical Devices Market Technology Movement Analysis
  • 5.3. Global AI-Enabled Medical Devices Market Size & Trend Analysis, by Technology, 2021 - 2033 (USD Million)
  • 5.4. Machine Learning Algorithms
    • 5.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.2. Deep learning
      • 5.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.3. Supervised
      • 5.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.4. Unsupervised
      • 5.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.5. Others
      • 5.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Natural Language Processing (NLP)
    • 5.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Computer Vision Techniques
    • 5.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Context-Aware Computing
    • 5.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. AI-Enabled Medical Devices Market: Therapeutic Area Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global AI-enabled Medical Devices Market Therapeutic Area Movement Analysis
  • 6.3. Global AI-enabled Medical Devices Market Size & Trend Analysis, by Therapeutic Area, 2021 - 2033 (USD Million)
  • 6.4. Cardiology
    • 6.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Neurology
    • 6.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Radiology
    • 6.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7. Oncology
    • 6.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.8. Mental and Behavioral Health
    • 6.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.9. Ophthalmology
    • 6.9.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.10. Others
    • 6.10.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. AI-Enabled Medical Devices Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global AI-Enabled Medical Devices Market End Use Movement Analysis
  • 7.3. Global AI-Enabled Medical Devices Market Size & Trend Analysis, by End Use, 2021 - 2033 (USD Million)
  • 7.4. Hospitals & Clinics
    • 7.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Diagnostic Centers
    • 7.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Ambulatory Surgical Centers (ASCs)
    • 7.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7. Home Care Settings
    • 7.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.8. Others
    • 7.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. AI-Enabled Medical Devices Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2021 - 2033:
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Norway
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. Australia
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. Argentina
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory framework
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Siemens Healthineers
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. GE Healthcare
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Philips Healthcare
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Medtronic
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Johnson & Johnson (Ethicon)
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Stryker
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Canon Medical Systems
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Zimmer Biomet
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Abbott Laboratories
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Boston Scientific
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Exo Imaging, Inc.
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Empatica
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. Aidoc
      • 9.4.13.1. Company overview
      • 9.4.13.2. Financial performance
      • 9.4.13.3. Product benchmarking
      • 9.4.13.4. Strategic initiatives
    • 9.4.14. Clew Medical
      • 9.4.14.1. Company overview
      • 9.4.14.2. Financial performance
      • 9.4.14.3. Product benchmarking
      • 9.4.14.4. Strategic initiatives
    • 9.4.15. Eko Health
      • 9.4.15.1. Company overview
      • 9.4.15.2. Financial performance
      • 9.4.15.3. Product benchmarking
      • 9.4.15.4. Strategic initiatives
    • 9.4.16. Paige AI, Inc.
      • 9.4.16.1. Company overview
      • 9.4.16.2. Financial performance
      • 9.4.16.3. Product benchmarking
      • 9.4.16.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global AI-enabled medical devices market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 4 Global AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 5 Global AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 6 Global AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 7 North America AI-enabled medical devices market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 9 North America AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 10 North America AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 11 North America AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 12 U.S. AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 13 U.S. AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 14 U.S. AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 15 U.S. AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Canada AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 17 Canada AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 18 Canada AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 19 Canada AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Mexico AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 21 Mexico AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 22 Mexico AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 23 Mexico AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Europe AI-enabled medical devices market, by country, 2021 - 2033 (USD Million)
  • Table 25 Europe AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 26 Europe AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 27 Europe AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 28 Europe AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 29 UK AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 30 UK AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 31 UK AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 32 UK AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 33 Germany AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 34 Germany AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 35 Germany AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 36 Germany AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 37 France AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 38 France AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 39 France AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 40 France AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Italy AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 42 Italy AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 43 Italy AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 44 Italy AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Spain AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 46 Spain AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 47 Spain AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 48 Spain AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 49 Denmark AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 50 Denmark AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 51 Denmark AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 52 Denmark AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 53 Sweden AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 54 Sweden AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 55 Sweden AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 56 Sweden AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 57 Norway AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 58 Norway AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 59 Norway AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 60 Norway AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific AI-enabled medical devices market, by country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 66 China AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 67 China AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 68 China AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 69 China AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Japan AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 71 Japan AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 72 Japan AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 73 Japan AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 74 India AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 75 India AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 76 India AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 77 India AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 78 South Korea AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 79 South Korea AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 80 South Korea AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 81 South Korea AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 82 Australia AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 83 Australia AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 84 Australia AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 85 Australia AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Thailand AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 87 Thailand AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 88 Thailand AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 89 Thailand AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 90 Latin America AI-enabled medical devices market, by country, 2021 - 2033 (USD Million)
  • Table 91 Latin America AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 92 Latin America AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 93 Latin America AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 94 Latin America AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 95 Brazil AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 96 Brazil AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 97 Brazil AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 98 Brazil AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 99 Argentina AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 100 Argentina AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 101 Argentina AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 102 Argentina AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 103 MEA AI-enabled medical devices market, by country, 2021 - 2033 (USD Million)
  • Table 104 MEA AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 105 MEA AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 106 MEA AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 107 MEA AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 108 South Africa AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 109 South Africa AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 110 South Africa AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 111 South Africa AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 116 UAE AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 117 UAE AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 118 UAE AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 119 UAE AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)
  • Table 120 Kuwait AI-enabled medical devices market, by component, 2021 - 2033 (USD Million)
  • Table 121 Kuwait AI-enabled medical devices market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 122 Kuwait AI-enabled medical devices market, by technology, 2021 - 2033 (USD Million)
  • Table 123 Kuwait AI-enabled medical devices market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Market formulation & validation
  • Fig. 5 AI-enabled medical devices market: Market outlook
  • Fig. 6 AI-enabled medical devices market: Segment outlook
  • Fig. 7 AI-enabled medical devices market: Competitive landscape outlook
  • Fig. 8 Parent market outlook
  • Fig. 9 AI-enabled medical devices market driver impact
  • Fig. 10 AI-enabled medical devices market restraint impact
  • Fig. 11 AI-enabled medical devices market: Component outlook and key takeaways
  • Fig. 12 AI-enabled medical devices market: Component movement analysis
  • Fig. 13 Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Hardware market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 AI-enabled medical devices market: Technology outlook and key takeaways
  • Fig. 18 AI-enabled medical devices market: Technology movement analysis
  • Fig. 19 Machine learning algorithms market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Deep learning market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Supervised market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Unsupervised market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Natural language processing (NLP) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Computer vision market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Context-aware computing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 AI-enabled medical devices market: Therapeutic area outlook and key takeaways
  • Fig. 28 AI-enabled medical devices market: Therapeutic area movement analysis
  • Fig. 29 Cardiology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Neurology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Radiology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Mental and behavioral health market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Ophthalmology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 AI-enabled medical devices market: End use outlook and key takeaways
  • Fig. 37 AI-enabled medical devices market: End use movement analysis
  • Fig. 38 Hospitals & clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Diagnostic centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Ambulatory surgical centers (ASCs) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Home care settings market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Global AI-enabled medical devices market: Regional outlook and key takeaways
  • Fig. 44 Global AI-enabled medical devices market: Regional movement analysis
  • Fig. 45 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 U.S. key country dynamics
  • Fig. 47 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Canada key country dynamics
  • Fig. 49 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Mexico key country dynamics
  • Fig. 51 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 UK key country dynamics
  • Fig. 54 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Germany key country dynamics
  • Fig. 56 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 France key country dynamics
  • Fig. 58 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Italy key country dynamics
  • Fig. 60 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Spain key country dynamics
  • Fig. 62 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Denmark key country dynamics
  • Fig. 64 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Sweden key country dynamics
  • Fig. 66 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Norway key country dynamics
  • Fig. 68 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Japan key country dynamics
  • Fig. 71 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 China key country dynamics
  • Fig. 73 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 India key country dynamics
  • Fig. 75 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Thailand key country dynamics
  • Fig. 77 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 South Korea key country dynamics
  • Fig. 79 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Australia key country dynamics
  • Fig. 81 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Brazil key country dynamics
  • Fig. 84 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Argentina key country dynamics
  • Fig. 86 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 South Africa key country dynamics
  • Fig. 89 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Saudi Arabia key country dynamics
  • Fig. 91 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 UAE key country dynamics
  • Fig. 93 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Kuwait key country dynamics
  • Fig. 95 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)